Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.02.2020 | Case report

Isoniazid/rifapentine

Urticaria and hepatotoxicity: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yu Y-Y, et al. Association of drug metabolic enzyme genetic polymorphisms and adverse drug reactions in patients receiving rifapentine and isoniazid therapy for latent tuberculosis. International Journal of Environmental Research and Public Health 17: 210, No. 1, Jan 2020. Available from: URL: http://doi.org/10.3390/ijerph17010210 CrossRef Yu Y-Y, et al. Association of drug metabolic enzyme genetic polymorphisms and adverse drug reactions in patients receiving rifapentine and isoniazid therapy for latent tuberculosis. International Journal of Environmental Research and Public Health 17: 210, No. 1, Jan 2020. Available from: URL: http://​doi.​org/​10.​3390/​ijerph17010210 CrossRef
Metadaten
Titel
Isoniazid/rifapentine
Urticaria and hepatotoxicity: 2 case reports
Publikationsdatum
01.02.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-75000-x

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Glycopyrrolate

Case report

Linezolid

Case report

Vancomycin

Case report

Antineoplastics